The research carried out on rats showed that it inhibits disruption of the dopaminergic system in PD as a result of the normalization of activity of the tyrosine hydroxylase (TH), an enzyme involved in the dopamine biosynthesis pathway [109] (Table 5). This evidence concerns the gene TH and Parkinson disease.